Military continues off-label drug use, despite concerns
Defense Department's inability to track prescriptions compounds the difficulty of measuring adverse medical effects.
The U.S Central Command continues to back the use of Seroquel, a powerful antipsychotic, to treat insomnia in troops deployed to combat zones despite an expert panel's recommendation six months ago to cease the practice. The drug, known generically as quetiapine, has been linked to adverse effects, including heart failure. Read the whole story at Nextgov.com.